- Home
- TARS vs SRPT Comparison
TARS vs SRPT Comparison
Compare TARS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- SRPT
- Stock Information
- Founded
- TARS 2016
- SRPT 1980
- Country
- TARS United States
- SRPT United States
- Employees
- TARS N/A
- SRPT N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- TARS Health Care
- SRPT Health Care
- Exchange
- TARS Nasdaq
- SRPT Nasdaq
- Market Cap
- TARS 1.7B
- SRPT 1.9B
- IPO Year
- TARS 2020
- SRPT 1997
- Fundamental
- Price
- TARS $69.09
- SRPT $23.13
- Analyst Decision
- TARS Strong Buy
- SRPT Hold
- Analyst Count
- TARS 7
- SRPT 31
- Target Price
- TARS $67.14
- SRPT $40.61
- AVG Volume (30 Days)
- TARS 737.2K
- SRPT 6.3M
- Earning Date
- TARS 11-12-2025
- SRPT 11-05-2025
- Dividend Yield
- TARS N/A
- SRPT N/A
- EPS Growth
- TARS N/A
- SRPT N/A
- EPS
- TARS N/A
- SRPT N/A
- Revenue
- TARS $295,521,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- TARS $137.28
- SRPT $9.41
- Revenue Next Year
- TARS $42.84
- SRPT N/A
- P/E Ratio
- TARS N/A
- SRPT N/A
- Revenue Growth
- TARS 254.45
- SRPT 64.89
- 52 Week Low
- TARS $32.91
- SRPT $10.42
- 52 Week High
- TARS $69.49
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- TARS 77.06
- SRPT 69.59
- Support Level
- TARS $56.25
- SRPT $17.57
- Resistance Level
- TARS $59.78
- SRPT $23.42
- Average True Range (ATR)
- TARS 2.58
- SRPT 1.34
- MACD
- TARS 1.15
- SRPT 0.66
- Stochastic Oscillator
- TARS 97.60
- SRPT 93.46
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.